KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Other Non-Current Liabilities (2016 - 2025)

Supernus Pharmaceuticals (SUPN) has disclosed Other Non-Current Liabilities for 15 consecutive years, with $22.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities rose 192.0% to $22.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $22.2 million, a 192.0% increase, with the full-year FY2025 number at $22.2 million, up 192.0% from a year prior.
  • Other Non-Current Liabilities was $22.2 million for Q4 2025 at Supernus Pharmaceuticals, up from $213000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $56.9 million in Q2 2022 to a low of $213000.0 in Q3 2025.
  • A 5-year average of $24.0 million and a median of $20.2 million in 2021 define the central range for Other Non-Current Liabilities.
  • Peak YoY movement for Other Non-Current Liabilities: tumbled 95.92% in 2023, then surged 450.72% in 2024.
  • Supernus Pharmaceuticals' Other Non-Current Liabilities stood at $35.6 million in 2021, then dropped by 5.02% to $33.8 million in 2022, then crashed by 95.92% to $1.4 million in 2023, then soared by 450.72% to $7.6 million in 2024, then soared by 192.0% to $22.2 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Other Non-Current Liabilities are $22.2 million (Q4 2025), $213000.0 (Q3 2025), and $7.5 million (Q1 2025).